Abstract
The effects of somatostatin-14 (SS-14) and the somatostatin-analog octreotide (SMS 201-995, Sandostatin) on proliferation of GH3 pituitary tumor cells were investigated in vitro. SMS 201-995 exerted a significant, but transient, inhibition on GH3 cell growth which reached a maximum at 24 h and was no longer detectable at 48 h. The concentration that evoked the strongest inhibitory effect was 10 nM SMS 201-995, while lower and higher doses resulted in a less pronounced effect. The inhibitory effect SMS 201-995 exerted on cell proliferation was associated with a dose- and time-related reduction in both c-myc and c-fos mRNA levels. SS-14 had no noteworthy influence on either cell proliferation or c-myc and c-fos protooncogene expression. These data demonstrate that SS-analogs transiently inhibit pituitary tumor cell proliferation in vitro.
Similar content being viewed by others
References
Schally A.V., Coy D.H., Meyers C.A. Hypothalamic regulatory hormones. Ann. Rev. Biochem. 47: 89, 1978.
Reichlin S.D. Somatostatin. N. Engl. J. Med. 309: 1495, 1556, 1983.
Bauer W., Briner U., Doepfener W., Haller R., Huguenin R., Marbach P., Petcher T.J., Pless J. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31:1133, 1982.
Gorden P., Comi R.J., Maton P.N., Vay Liang W.G. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non neo plastic diseases of the gut. Ann. Intern. Med. 110: 35, 1989.
Lamberts S.W.J., Uitterlinden P., Verschoor L, van Dongen K.J., Del Pozo E. Long-term treatment of acromegaly with the somatostatin analog SMS 201-995. N. Engl. J. Med. 313:1576, 1985.
Kraenzlin M.E., Chang J.C., Wood S.M., Bloom S.R. Can inhibition of hormone secretion be associated with endocrine tumor shrinkage? Lancet 2: 1501, 1983.
Lamberts S.W.J., Reubi J.C., Uitterlinden P., Zuiderwijk P., van den Werff P., van Hal P. Studies on the mechanism of action of the inhibitory effect of somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a. Endocrinology 118: 2188, 1986.
Redding T.W., Schally A.V. Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Proc. Natl. Acad. Sci. USA 81: 248, 1984.
Schally A.V. Oncological applications of somatotatin analogues. Cancer Res. 487: 6977, 1988.
Tasjan A.H. Jr. Clonal strains of hormone-producing pituitary cells. Meth. Enzymol. 58:527, 1979.
Pagé M., Bejaoui N., Cinq-Mars B., Lemieux P. Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharm. 10: 785, 1988.
Dalla Favera R., Martinotti S., Gallo R.C., Erikson J., Croce C.M. Translocation and rearrangement of the c-myc oncogene locus in human undifferentiated β-cell lymphomas. Science 219: 963, 1983.
Curran T., MacConnel W.P., van Straaten F., Verma I.M. Structure of the. FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells. Mol. Cell. Biol. 3:914, 1983.
Maniatis T., Fritsch E.F., Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, 1982.
Reisine T., Axelrod J. Prolonged somatostatin pretreatment desensitizes somatostatin’s inhibition of receptor mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase. J. Endocrinol. 113: 811, 1983.
Viguerie N., Tahirijouti N., Ayral A.M., Cambillau C., Scemama J.L., Bastie M.J., Knuthsen S., Esteve J.P., Pradayrol L., Susini C. Vaysse N. Direct inhibitory effects of a somatostatin analog SMS 201-995, on Ar4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-indipendent mechanism. Endocrinology 124: 1017, 1989.
Setyono-Han B., Henkelman M.S., Foekens J.A., Klijn J.G.M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 47: 1566, 1987.
Reisine T., Zhang Y., Sekura R. Pertussis toxin blocks somatostatin’s inhibition of stimulated cyclic AMP accumulation in anterior pituitary cells. Biochem. Biophys. Res. Commun. 115: 794, 1983.
Armelin H.A., Armelin M.C.S., Kelly K., Stewart T., Leder P., Cochran B.H., Stiles C.D. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 310: 655, 1984.
Cochran B.H., Zullo J., Verma I.M., Stiles C.D. Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor. Science 226: 1080, 1984.
Hinkle P.M., Kinsella P.A. Thyroid hormone induction of an autocrine growth factor secreted by pituitary tumor cells. Science 234: 1549, 1986.
Liebow C., Reilly C., Serrano M., Schally A.V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 86: 2003, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pelicci, G., Pagliacci, M.C., Lanfrancone, L. et al. Inhibitory effect of the somatostatin analog octreotide on rat pituitary tumor cell (GH3) proliferation in vitro . J Endocrinol Invest 13, 657–662 (1990). https://doi.org/10.1007/BF03349589
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349589